- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04430803
Hydrogen-rich Water for Molecular and Phenotypic Biomarkers of Aging (H2AGE)
April 26, 2021 updated by: University of Novi Sad, Faculty of Sport and Physical Education
The Effects of Six-month Hydrogen-rich Water Intake on Molecular and Phenotypic Biomarkers of Aging in Men and Women Aged 70 Years and Over: a Randomized-controlled Trial
This study evaluates the effects of six-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in men and women aged 70 years and over.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Vojvodina
-
Novi Sad, Vojvodina, Serbia, 21000
- FSPE Applied Bioenergetics Lab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
68 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age > 70 years
- Free of acute disorders
Exclusion Criteria:
- History of dietary supplement use during the past 4 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hydrogen-rich water
Hydrogen-rich water (Rejuvenation, HRW Natural Health Products Inc.)
|
A tablet that produces hydrogen dissolved in a glass of water
|
Placebo Comparator: Control water
Tap water
|
A glass of tap water
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in TeloTAGGG Telomerase PCR activity in serum
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in DNA methylation
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in blood concentration of advanced glycation end product
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in lipid peroxidation
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in serum FGF21
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in serum TET2
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in ADAS-Cog score (0-70 scale, higher scores indicating greater cognitive impairment)
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in facial wrinkling (0-100 scale; higher scores mean worse outcome)
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Change in maximal oxygen uptake estimated by step-in-place test
Time Frame: Baseline vs. 6 months post-intervention
|
Baseline vs. 6 months
|
Baseline vs. 6 months post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Xia X, Chen W, McDermott J, Han JJ. Molecular and phenotypic biomarkers of aging. F1000Res. 2017 Jun 9;6:860. doi: 10.12688/f1000research.10692.1. eCollection 2017.
- Zanini D, Todorovic N, Korovljev D, Stajer V, Ostojic J, Purac J, Kojic D, Vukasinovic E, Djordjievski S, Sopic M, Guzonjic A, Ninic A, Erceg S, Ostojic SM. The effects of 6-month hydrogen-rich water intake on molecular and phenotypic biomarkers of aging in older adults aged 70 years and over: A randomized controlled pilot trial. Exp Gerontol. 2021 Nov;155:111574. doi: 10.1016/j.exger.2021.111574. Epub 2021 Oct 1.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2020
Primary Completion (Actual)
March 15, 2021
Study Completion (Actual)
April 1, 2021
Study Registration Dates
First Submitted
June 7, 2020
First Submitted That Met QC Criteria
June 11, 2020
First Posted (Actual)
June 12, 2020
Study Record Updates
Last Update Posted (Actual)
April 27, 2021
Last Update Submitted That Met QC Criteria
April 26, 2021
Last Verified
April 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 281048E-HRW/2020
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
Amazentis SAproDERM GmbHCompleted
-
Northumbria UniversityUniversity of East AngliaSuspendedSleep | Aging | Healthy AgingUnited Kingdom
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
Clinical Trials on Hydrogen-rich water
-
Navy General Hospital, BeijingRecruitingChronic Graft-versus-host DiseaseChina
-
University of Novi Sad, Faculty of Sport and Physical...Completed
-
Qingdao UniversityQingdao Hiser Medical GroupRecruitingType 2 DiabetesChina
-
Sun JiaRecruiting
-
Palacky UniversityCompletedOxidative Stress | Athletic Performance | Muscle FatigueCzechia
-
Kaohsiung Medical University Chung-Ho Memorial...Active, not recruitingQuality of Life | Pain | Head and Neck Cancer | Oral MucositisTaiwan
-
Palacky UniversityCompletedOxidative Stress | Athletic Performance | Muscle FatigueCzechia
-
Stony Brook UniversityNatural Wellness Now Health ProductsRecruitingMyalgic Encephalomyelitis/Chronic Fatigue SyndromeUnited States
-
Stony Brook UniversityCompletedChronic Fatigue SyndromeUnited States
-
Stony Brook UniversityNatural Wellness Now Health ProductsRecruitingChronic Fatigue SyndromeUnited States